chr11-102608938-G-A
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1
The NM_004771.4(MMP20):c.810C>T(p.Tyr270=) variant causes a splice region, synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00387 in 1,613,820 control chromosomes in the GnomAD database, including 218 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★). Synonymous variant affecting the same amino acid position (i.e. YG270*) has been classified as Pathogenic.
Frequency
Consequence
NM_004771.4 splice_region, synonymous
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -21 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
MMP20 | NM_004771.4 | c.810C>T | p.Tyr270= | splice_region_variant, synonymous_variant | 5/10 | ENST00000260228.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
MMP20 | ENST00000260228.3 | c.810C>T | p.Tyr270= | splice_region_variant, synonymous_variant | 5/10 | 1 | NM_004771.4 | P1 | |
MMP20-AS1 | ENST00000542119.1 | n.86+1486G>A | intron_variant, non_coding_transcript_variant | 3 |
Frequencies
GnomAD3 genomes AF: 0.0203 AC: 3089AN: 152080Hom.: 117 Cov.: 32
GnomAD3 exomes AF: 0.00538 AC: 1353AN: 251464Hom.: 45 AF XY: 0.00372 AC XY: 506AN XY: 135900
GnomAD4 exome AF: 0.00216 AC: 3155AN: 1461622Hom.: 102 Cov.: 32 AF XY: 0.00183 AC XY: 1330AN XY: 727128
GnomAD4 genome AF: 0.0203 AC: 3095AN: 152198Hom.: 116 Cov.: 32 AF XY: 0.0191 AC XY: 1422AN XY: 74420
ClinVar
Submissions by phenotype
not provided Benign:3
Benign, criteria provided, single submitter | clinical testing | GeneDx | Jun 09, 2021 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 31, 2019 | - - |
Amelogenesis imperfecta hypomaturation type 2A2 Benign:1
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 13, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at